0001415889-24-009606.txt : 20240401
0001415889-24-009606.hdr.sgml : 20240401
20240401185145
ACCESSION NUMBER: 0001415889-24-009606
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240328
FILED AS OF DATE: 20240401
DATE AS OF CHANGE: 20240401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRAY MARY ANN
CENTRAL INDEX KEY: 0001261974
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38997
FILM NUMBER: 24811640
MAIL ADDRESS:
STREET 1: 201 W 70TH ST, SUITE 23K
CITY: NEW YORK
STATE: NY
ZIP: 10023
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RAPT Therapeutics, Inc.
CENTRAL INDEX KEY: 0001673772
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473313701
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 489-9000
MAIL ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: FLX Bio, Inc.
DATE OF NAME CHANGE: 20160504
4
1
form4-04012024_100439.xml
X0508
4
2024-03-28
0001673772
RAPT Therapeutics, Inc.
RAPT
0001261974
GRAY MARY ANN
C/O RAPT THERAPEUTICS, INC.
561 ECCLES AVENUE
CA
94080
true
false
false
false
0
Stock Option (right to buy)
8.98
2024-03-28
4
A
0
8574
7.58
A
2034-03-27
Common Stock
8574
8574
D
The shares subject to the option vest in four equal quarterly installments on the last day of each fiscal quarter in 2024 with the first installment vesting on March 31, 2024, provided that the reporting person is in service as a director on each such vesting date.
This option was issued to the reporting person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of an annual cash retainers for service on the Board of Directors and committees thereof in the aggregate amount of $65,000.
/s/ Rodney Young, Attorney-in-Fact
2024-04-01